Sergio Copete

Sergio Copete

Auto-generated profile, based on publicly available information

Sergio Copete

University Hospital Complex of Albacete, Ophthalmology Department, Albacete, Spain

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 January 2021 in Orbit
Verified
Journal Article
Closed access
MDMónica Martínez Díaz
Mónica Martínez Díaz
SPSergio Copete Piqueras
Sergio Copete Piqueras
CMCristina Blanco Marchite
Cristina Blanco Marchite
KVKaveh Vahdani
Kaveh Vahdani
We describe a retrospective case report of dacryoadenitis associated with orbital inflammatory disease in a patient with confirmed SARS-CoV-2 infection. A 22-year-old previously fit and healthy male presented with 4-day history of right ocular redness, eyelid swelling and blurred vision associated with discomfort and pain in the lacrimal gland area. He was found to have right acute dacryoadenitis based on clinical examination and orbital imaging. One day after initiation of oral antibiotic and non-steroidal anti-inflammatory therapy, he developed worsening of the orbital inflammation and partial ophthalmoplegia. Oral steroids were commenced resulting in rapid resolution of symptoms within a few days and clinical stability at 2 months. The patient did not have any systemic features of COVID-19 but he was in close contact with his mother and with his partner who both had respiratory symptoms and tested positive for SARS-CoV-2 antigen (PCR testing) 4 weeks prior. PCR testing from nasopharyngeal swab was negative for SARS-CoV-2 RNA; however, the serological test was positive for IgM/IgG SARS-CoV-2 antibodies. Extensive laboratory workup including infectious and autoimmune screening and chest x-ray were unremarkable. Orbital inflammatory disease due to infectious process or immunological response may potentially occur in COVID-19 patients, although the causal relationship remains uncertain.

6 January 2012 in Graefe's Archive for Clinical and Experimental Ophthalmology
Verified
Journal Article
Closed access
PDF file
SCSergio Copete
Sergio Copete
José M Ruiz-MorenoJosé M Ruiz-Moreno
José M Ruiz-Moreno
CCCarlos Cava
Carlos Cava
JMJavier A. Montero
Javier A. Montero

1 November 2019 in Retina
Verified
Journal Article
Closed access
SCSergio Copete
Sergio Copete
PMPablo Martí-Rodrigo
Pablo Martí-Rodrigo
RMRomina Muñiz-Vidal
Romina Muñiz-Vidal
Salvador Pastor-IdoateSalvador Pastor-Idoate
Salvador Pastor-Idoate
JRJaume Rigo
Jaume Rigo
MZMiguel Angel Zapata
Miguel Angel Zapata
Purpose: We assessed the role of vitreoretinal interface status in the development of pseudophakic cystoid macular edema (PCME) after cataract surgery. Methods: Prospective cohort study in which 112 patients (112 eyes) scheduled for cataract surgery were selected at random to undergo spectral domain optical coherence tomography (OCT) within 1 week preoperatively and at 1 and 3 months postoperatively. Spectral domain OCT macular images included no vitreoretinal contact, focal and diffuse vitreomacular adhesion, focal and diffuse vitreomacular traction, epiretinal membrane, macular hole, and macular edema. Results: The incidence of PCME was 11.6% (13 eyes), all of them being diagnosed at 1 month, and 7 eyes resolved at 3 months. The only risk factor for PCME was detection of nonsurgical epiretinal membrane by spectral domain OCT before phacoemulsification, being developed in 5 of 16 eyes (χ2 = 0.08, odds ratio 4.53, 95% confidence interval 1.28–16.13). Other variables such as posterior vitreous detachment, subfoveal choroidal thickness, diabetes, or hypertension were not significantly associated with PCME. Conclusion: In this cohort, preoperative detection of epiretinal membrane by spectral domain OCT was a risk factor for PCME after cataract extraction. It is recommended to perform a spectral domain OCT before cataract surgery because the presence of an epiretinal membrane may be passed unnoticed by fundus examination.

25 July 2025 in Eye
Verified
Journal Article
Closed access
CCCarlos Campo-Beamud
Carlos Campo-Beamud
VSVictoria Hernando Sebastián
Victoria Hernando Sebastián
ECEsther Campo-Beamud
Esther Campo-Beamud
FGFrancisco Javier Gómez-Romero
Francisco Javier Gómez-Romero
ARAndrea Donate Rosa
Andrea Donate Rosa
SCSergio Copete
Sergio Copete

17 January 2024 in Expert Opinion on Drug Safety
Verified
Journal Article
Closed access
AMAlmudena Moreno-Martinez
Almudena Moreno-Martinez
CBCristina Blanco-Marchite
Cristina Blanco-Marchite
SCSergio Copete
Sergio Copete
Intravitreal dexamethasone implant (DEXI) has been placed as an effective option to treat diabetic macular edema (DME). However, there is no consensus on the best time to introduce it. We conducted a study to evaluate anatomical and functional behavior after the first DEXI according to previous treatment. This retrospective, real-world study between 2013 and 2020 investigated changes in best-corrected visual acuity (BCVA) and central macular thickness (CMT at months 2 and 6 after the first DEXI in DME. Patients were divided into naive, early switch (≤3 anti-VEGF injections), or late switch (>3 anti-VEGF injections) groups. Among 112 consecutive eyes, mean BCVA and CMT improved significantly in all groups at month 2, with no difference between them. However, this improvement was not maintained at 6 months. The Naíve group presented better BCVA all over the study period. The previously treated groups, which started with worse initial visual acuity, showed more visual gain without reaching the BCVA of the naive group. CMT performance was similar between groups. There was similar anatomical and functional behavior in all groups. Poorer visual acuity at baseline was associated with worse functional outcome despite good anatomic response.

1 January 2022 in Travel Medicine and Infectious Disease
Verified
Journal Article
Closed access
DEDenisse Espinosa-Encalada
Denisse Espinosa-Encalada
SPSergio Copete Piqueras
Sergio Copete Piqueras
ACAlfonso Gómez Cortés
Alfonso Gómez Cortés
CMCristina Isabel Blanco Marchite
Cristina Isabel Blanco Marchite